Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome

BJU International

Volumn 113, Issue 5 B, 2014, Pages

  Luo, Hao Lun ^a,b   Chen, Yen Ta ^b   Chuang, Yao Chi ^b   Cheng, Yuan Tso ^b   Lee, Wei Ching ^b   Kang, Chih Hsiung ^b   Chiang, Po Hui ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Neutrophil to lymphocyte; Upper urinary tract; Urothelial carcinoma

Indexed keywords

AGED; ARTICLE; BLADDER SURGERY; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS FREE SURVIVAL; NEPHROURETERECTOMY; NEUTROPHIL COUNT; NEUTROPHIL TO LYMPHOCYTE RATIO; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; URINARY TRACT CARCINOMA; BLOOD; CLASSIFICATION; KIDNEY TUMOR; LYMPHOCYTE; NEUTROPHIL; NEUTROPHIL TO LYMPHOCYTE; PROGNOSIS; RETROSPECTIVE STUDY; URETER TUMOR; URINARY TRACT;

NEUTROPHIL TO LYMPHOCYTE; UPPER URINARY TRACT; UROTHELIAL CARCINOMA;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPHOCYTES; MALE; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; URETERAL NEOPLASMS;

EID: 84902325503     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12582     Document Type: Article

References (21)

1. Wittekind C. 2010 TNM system: on the 7th edition of TNM classification of malignant tumors. Pathologe 2010; 31: 331-2
2. Shariat SF, Zigeuner R, Rink M et al. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. Eur Urol 2012; 62: 224-31
3. Ohno Y, Nakashima J, Ohori M et al. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol 2010; 184: 873-8
4. Gondo T, Nakashima J, Ohno Y et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology 2012; 79: 1085-91
5. Azab B, Shah N, Radbel J et al. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol 2012; 30: 432-42
6. Perez DR, Baser RE, Cavnar MJ et al. Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Ann Surg Oncol 2013; 20: 593-9
7. Cetin B, Berk V, Kaplan MA et al. Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastatic renal cell carcinoma? Clin Genitourin Cancer 2013; 11: 141-8
8. Lughezzani G, Burger M, Margulis V et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 2012; 62: 100-14
9. Rink M, Robinson BD, Green DA et al. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol 2012; 188: 398-404
10. Vassilakopoulou M, de la Motte Rouge T, Colin P et al. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UTUC): results from a large multicenter collaborative study. Cancer 2011; 117: 5500-8
11. Kang CH, Chiang PH, Huang SC. Correlation of COX-2 expression in stromal cells with high stage, high grade, and poor prognosis in urothelial carcinoma of upper urinary tracts. Urology 2008; 72: 153-7
12. Hashimoto T, Ohno Y, Nakashima J et al. Clinical significance of preoperative peripheral blood neutrophil count in patients with non-metastatic upper urinary tract carcinoma.World J Urol 2013; 31: 953-8
13. Tachibana M, Miyakawa A, Tazaki H et al. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res 1995; 55: 3438-43
14. Okamoto M, Hattori K, Oyasu R. Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. Int J Cancer 1997; 72: 149-54 (Pubitemid 27314652)
15. De Larco JE, Wuertz BR, Furcht LT. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 2004; 10: 4895-900 (Pubitemid 39099762)
16. Rodriguez PC, Ernstoff MS, Hernandez C et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009; 69: 1553-60
17. Muller I, Munder M, Kropf P et al. Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends Immunol 2009; 30: 522-30
18. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004; 21: 137-48 (Pubitemid 39094044)
19. Morgan RA, Dudley ME, Wunderlich JR et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006; 314: 126-9 (Pubitemid 44547756)
20. Mahmoud SM, Paish EC, Powe DG et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 2011; 29: 1949-55
21. Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology 2007; 121: 1-14 (Pubitemid 46537674)